Genoptix, a NeoGenomics Company Right Answer, Right Now Advancing positive outcomes in oncology through innovation, quality and service Oncology Expertise For almost 20 years, Genoptix, a NeoGenomics Company, has provided the vital insights cancer care teams need to achieve the best possible outcome for each and every patient. Our broad menu of testing solutions spans from pathology expertise to next-generation testing, enabling confident decisions in optimizing precision medicine. Having diagnosed over 1.7 million patients and counting, Genoptix sets a higher standard of quality, from science to service. Because what matters most is delivering the right answer, right now. For more details, see http://www.genoptix.com. For the latest news, visit NeoGenomics Laboratories at https://www.linkedin.com/company/neogenomics-laboratories.